172 related articles for article (PubMed ID: 6142849)
41. [Refractory duodenal ulcer: an emerging therapeutic problem].
Bianchi Porro G; Parente F
Medicina (Firenze); 1988; 8(1):27-33. PubMed ID: 2906398
[No Abstract] [Full Text] [Related]
42. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
Naesdal J; Bodemar G; Walan A
Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
[TBL] [Abstract][Full Text] [Related]
43. Suppression of gastric acidity in horses.
Murray MJ
J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
[No Abstract] [Full Text] [Related]
44. [New developments in drug therapy: omeprazole].
Koop H
Z Gastroenterol Verh; 1991 Mar; 26():159-61. PubMed ID: 1714134
[No Abstract] [Full Text] [Related]
45. [Adverse effects of H2 blockaders].
Arabehety AR
Acta Gastroenterol Latinoam; 1980; 10(4):317-23. PubMed ID: 6115533
[No Abstract] [Full Text] [Related]
46. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
Carrère MO; Auquier P; Poynard T; Sambuc R
Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
[TBL] [Abstract][Full Text] [Related]
47. [Progress in research on ulcer therapy?].
Gugler R
Z Gastroenterol; 1986 Mar; 24(3):149-51. PubMed ID: 3518259
[No Abstract] [Full Text] [Related]
48. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
49. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer].
Shcherbak VV; Glubochenko VG; Zaĭdman VE
Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438
[No Abstract] [Full Text] [Related]
50. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
51. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
[TBL] [Abstract][Full Text] [Related]
52. [Further development of the H2-blocker in ulcer therapy].
Domschke S; Domschke W
Med Klin; 1981 Jan; 76(3):68-73. PubMed ID: 6111744
[No Abstract] [Full Text] [Related]
53. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
54. Histamine H2 antagonists.
Langman MJ
Practitioner; 1979 Oct; 223(1336):500-5. PubMed ID: 523402
[No Abstract] [Full Text] [Related]
55. Duodenal ulcers that will not heal.
Pounder RE
Gut; 1984 Jul; 25(7):697-702. PubMed ID: 6329922
[No Abstract] [Full Text] [Related]
56. Use and abuse of H2 receptor antagonists.
Hunt RH
J R Coll Physicians Lond; 1982 Jan; 16(1):33-9. PubMed ID: 6121053
[No Abstract] [Full Text] [Related]
57. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
Vallot T; Mignon M
Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
[No Abstract] [Full Text] [Related]
58. [Conservative therapy of peptic ulcer].
Clémençon GH
Schweiz Med Wochenschr; 1980 Oct; 110(41):1474-82. PubMed ID: 6106967
[TBL] [Abstract][Full Text] [Related]
59. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
60. Peptic ulcer in the Royal Navy.
Hunt RH
J R Nav Med Serv; 1981; 67(3):125-30. PubMed ID: 6121054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
